CDY2 Activators can be described as a chemical class formulated to specifically interact with and enhance the activity of the protein encoded by the CDY2 gene, which is a member of the chromodomain Y-linked family of proteins. These proteins are known for their role in histone modification and are implicated in the regulation of transcription through chromatin remodeling. Activators in this case would be specialized molecules that bind to the CDY2 protein, potentially leading to heightened activity of the protein's histone acetyltransferase function or enhancing its role in chromatin remodeling. The development of such activators would involve comprehensive structural and functional studies of the CDY2 protein to identify domains that are amenable to small molecule interaction. Techniques like X-ray crystallography, NMR spectroscopy, or cryo-EM would serve to elucidate the three-dimensional structure of CDY2, pinpointing potential binding sites for activators.
Once potential activator-binding sites on CDY2 are characterized, the chemical synthesis of candidate molecules would commence, guided by structure-based drug design principles. This would involve the use of computational chemistry tools to virtually screen large libraries of compounds for their ability to fit within the binding sites of CDY2, followed by in vitro testing to validate the computational predictions. High-throughput screening might also be employed to empirically test diverse chemical libraries for compounds that increase the activity of CDY2. Subsequent biochemistry-based assays, such as fluorescence resonance energy transfer (FRET) or bioluminescence resonance energy transfer (BRET), could be used to measure the binding affinity of these activators to the CDY2 protein and their ability to modulate its function. This iterative process of design, synthesis, and testing would yield a collection of molecules classified as CDY2 Activators, each with the potential to selectively enhance the activity of the CDY2 protein. Such molecules would be valuable in advancing the understanding of the biological processes governed by CDY2, providing insight into the molecular mechanisms of chromatin organization and gene expression regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May demethylate DNA, potentially activating gene expression including that of CDY2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it could upregulate gene expression by altering chromatin structure. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Another histone deacetylase inhibitor that may increase CDY2 expression by easing chromatin compaction. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in the regulation of spermatogenesis, could influence CDY2 expression in testicular tissue. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
It has roles in cell growth and development which might include upregulation of certain genes in testicular cells. | ||||||
Folic Acid | 59-30-3 | sc-204758 | 10 g | $73.00 | 2 | |
Essential for DNA synthesis and repair, may upregulate genes involved in cell division like CDY2. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc plays a crucial role in reproductive health and could affect the expression of genes like CDY2. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
An endocrine disruptor that might alter gene expression patterns in reproductive tissues. | ||||||
Di-n-butyl phthalate | 84-74-2 | sc-257307 sc-257307A sc-257307B | 5 g 25 g 1 kg | $41.00 $52.00 $104.00 | 1 | |
Another endocrine disruptor potentially influencing gene expression in the testes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol that may have epigenetic modulating activity affecting gene expression. | ||||||